1. Preresection serum C-reactive protein measurement and survival among patients with resectable non–small cell lung cancer 
Marco Alifano, MD, PhD, Pierre E. Falcoz, MD, PhD, Valérie Seegers, MD, Nicolas Roche, MD, PhD, Olivier Schussler, MD, PhD, Mohamad Younes, MD, Filippo Antonacci, MD, Patricia Forgez, PhD, Agnes Dechartres, MD, Gilbert Massard, MD, Diane Damotte, MD, PhD, Jean-François Régnard, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 142, Issue 5, Pages (November 2011)
DOI: /j.jtcvs
Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Kaplan-Meier estimates of survival. A, Overall survival in the main cohort. B, Survival curves of patients with stages I and II in the main cohort according to the C-reactive protein (CRP) levels. C, Survival curves of patients with stages III and IV in the main cohort according to the C-reactive protein levels. D, Survival curves in the validation cohort according to the C-reactive protein levels.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions